Meitav Dash Investments LTD Neuro Sense Therapeutics Ltd. Call Options Transaction History
Meitav Dash Investments LTD
- $5.8 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRSN
# of Institutions
8Shares Held
225KCall Options Held
0Put Options Held
0-
Cantor Fitzgerald, L. P. New York, NY79.5KShares$73,9270.01% of portfolio
-
Xtx Topco LTD London, X046KShares$42,7760.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il34.3KShares$31,8800.0% of portfolio
-
Commonwealth Equity Services, LLC12.6KShares$11,7410.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12KShares$11,1250.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $10.9M